Lise Hébert, PhD has served as our President and Chief Executive Officer and as a member of our board of directors since April 2009. Prior to joining our company, Dr. Hébert served as vice president of Corporate Communications at Bellus Health Inc., a biotechnology company, for over 10 years. Dr. Hébert holds a PhD in Experimental Medicine from McGill University, where her research focused on amyloidosis and during which time she also conducted research at New York University Medical School. Dr. Hébert completed her post-doctoral studies at the Lady Davis Research Institute at the Montreal Jewish General Hospital and she is the author of several patents. She currently serves on the Life Sciences Committee of the Fédération des Chambres du Commerce du Québec.
Dr. Lise Hébert
Mr. Mariano Rodriguez
Mariano Rodriguez, CPA, CA has served as our Chief Financial Officer and Senior Vice President of Corporate Development since November 2014 and previously served as our Vice President and Chief of Finance and Operations since August 2011. From May 2009 to August 2011, he was the executive vice president and chief financial officer of GFI Solutions Group Inc., an information technology software and services company. From January 2005 to May 2009, he was vice president and chief financial officer of Bellus Health Inc. and previously served as vice president and chief financial officer of Galileo Genomics Inc., a biotechnology company. He began his career at Ernst & Young LLP. Mr. Rodriguez holds a diploma in Public Accounting and a Bachelor of Commerce degree from McGill University, and is also a certified CPA, CA in Canada and CPA in the United States.
Dr. Michel Cimon
Michel Cimon, MD. has served as Vice-President Clinical and Medical Affairs since May 2015. Prior to joining our company, Dr. Cimon was heading a medical team of more than 400 physicians at the Lanaudière Health Authority for 3 years.
From 2006 to 2007 he was the Director of Medical Affairs at Merck Canada and in 2008 was promoted to the position of Vice-President Medical Affairs which he held until the end of 2011. In that capacity he was overseing the teams of clinical research, medical affairs, regulatory affairs and pharmacovigilance. Prior to Merck, he was the Vice-President of Scientific Affairs of Berlex Canada from 2005 to 2006.
Dr. Cimon has also worked for GSK Canada for more than 10 years where he held different positions of increasing responsibilities always in the role of Director of Professionnal and Medical Affairs.
He holds a B.Sc in Physiology from McGill University, he also holds an Medical degree from Sherbrooke University and a MPH degree from the University of California in Berkeley.
Mr. Jason Gugliuzza
Prior to joining our company Mr Gugliuzza has worked in various senior sales and marketing roles for various multinational organizations. Most recently, he served as the Senior Vice President for Japan and Asia at Acelity, the largest wound care business globally today.
Previously he was the Regional Vice President and Vice President of Commercial strategy for the Emerging Markets region at Acelity working across all of the ASIA, MENA and Latin American regions.
A seasoned Sales and marketing professional with twenty years working in healthcare, he has worked and lived in Europe, AISA and North America with experience of the Wound Care, Respiratory Pharmaceuticals and Dermatology segments, specifically with companies such as AstraZeneca, Smith and Nephew and ConvaTec.
Mr Gugliuzza holds an MBA from the University of Durham, an MSc in International Business and Corporate Finance and an undergraduate degree in Economics.
Mr. Trevor Arsenault
Trevor Arsenault serves as the VP Business Development and Alliances and leads the partnership and business development activities.
He has a rich career in Healthcare holding global positions in generic and branded companies. Previously, Trevor was Vice President & General Manager International at Pharmascience Inc., a privately held global pharmaceutical company headquartered in Montreal that sells over 400 products, including branded prescription, OTC and BTC , and generic products. Trevor was also a Director for Pharmascience Korea, a joint venture with Kolmar Korea, a company focused on specialty medicines, namely those for the central nervous system. Before joining Pharmascience, Trevor held senior Commercial positions at Bristol Myers Squibb Co. from 2004 to 2010, including Vice-President of Immunology, Virology, & CNS for Bristol Myers Squibb Canada Co. and Global Director of Market Access BMS Headquarters in Princeton, NJ.
He is passionate about giving back and is past Board President of a cancer charity, Venturing Out Beyond Our Cancer (VOBOC), which provides adolescents and young adults with customized care packages located in Montreal. Mr Arsenault holds a Bachelor of Business Administration from University of New Brunswick.